China Spinal Cord Injury Network

China Spinal Cord Injury Network (ChinaSCINet) is a non-profit clinical trial network dedicated to developing and testing therapies for spinal cord injury (SCI). Founded in 2005 by Dr. Wise Young, the organization facilitates large-scale, multi-center clinical trials across Mainland China, Hong Kong, and Taiwan. The network's primary research focus involves the transplantation of umbilical cord blood mononuclear cells (UCBMC) combined with lithium carbonate and intensive locomotor training. ChinaSCINet aims to establish standardized clinical trial protocols and provide evidence-based treatments for patients with chronic, complete spinal cord injuries. Their work represents one of the most significant global efforts to bring regenerative cell therapies to the SCI patient population through rigorous clinical testing. The network bridges international clinical standards with the extensive patient resources available in the Greater China region.